Myrrh protects against IL-13-induced epithelial barrier breakdown in HT-29/B6 cells

Area of Science:

• Gastroenterology
• Cell Biology
• Pharmacology

Background:

• The intestinal epithelial barrier is crucial for gut health, preventing pathogen entry and maintaining homeostasis.
• Inflammatory conditions like ulcerative colitis severely compromise barrier integrity, leading to diarrhea and immune responses.
• Myrrh has a long history of use as an anti-inflammatory agent with potential gut-protective properties.

Purpose of the Study:

• To investigate the protective effects of myrrh on the intestinal epithelial barrier under inflammatory conditions induced by Interleukin-13 (IL-13).
• To elucidate the molecular mechanisms underlying myrrh's protective action against IL-13-induced barrier dysfunction in a human intestinal cell model.

Main Methods:

• Utilized HT-29/B6 human intestinal epithelial cell monolayers to assess barrier function.
• Measured transepithelial electrical resistance (TEER) to quantify barrier integrity.
• Analyzed tight junction protein expression (claudin-2, tricellulin) and apoptosis.
• Investigated the involvement of STAT3 and STAT6 signaling pathways.

Main Results:

• IL-13 significantly impaired epithelial barrier function, which was fully restored by myrrh treatment.
• Myrrh prevented IL-13-induced upregulation of claudin-2 and altered tricellulin localization.
• Myrrh reduced IL-13-induced apoptosis and protected against tight junction deregulation.
• Protective effects were associated with the inhibition of STAT3 and STAT6 pathways.

Conclusions:

• Myrrh demonstrates significant protective effects against IL-13-induced intestinal barrier impairment in vitro.
• Myrrh normalizes tight junction protein expression and reduces apoptosis, thereby enhancing barrier function.
• These findings support the potential of myrrh as a therapeutic agent for inflammatory bowel diseases.